Generic Drugs Market Forecast 2016-2026: Growth in Leading Regional and National Markets

Tuesday, June 7, 2016 Drug News
Email Print This Page Comment bookmark
Font : A-A+

NEW YORK, June 6, 2016 /PRNewswire/ --Report DetailsWhat can be expected from the Generic Drugs Market? Which areas

are going to grow at the fastest rates? This visiongain report shows you potential revenues to 2026, assessing data, trends, opportunities and prospects.Our 306-page report provides 175 tables, charts, and graphs. Discover the most lucrative areas in
the industry and the future market prospects. Our new study lets you assess forecasted sales across all the major regional and national generic drugs market. You will see financial results, trends, opportunities, and revenue predictions. There is much opportunity in this fast moving market.Forecasts from 2016-2026 and other analyses show you commercial prospectsBesides revenue forecasting to 2026, our new study provides you with recent results, growth rates, and market shares. Discover qualitative analyses (including SWOT analysis) and commercial developments.See detailed profiles or revenue forecasts for some of the leading regions in the generic drugs market- US- EU5- Asia-Pacific- Emerging marketsSee revenue forecasts for the leading international marketsHow will leading national and regional markets perform to 2026? Our study forecasts revenues in national markets, including:- US- Germany- UK- France- Italy- Spain- China- Japan- India- Brazil- Russia- Mexico- South Korea- TurkeyLeading companies and potential for market growthVisiongain forecasts overall revenue for the Generic Drugs Market will reach $254.6bn in 2016. We predict a high revenue growth over the forecast period driven by an ageing population, healthcare cost saving strategies and rapid growth of emerging economies.Our work analyses the key companies in the market. See visiongain's analysis of ten leading companies, including:- Teva- Novartis (Sandoz)- Allergan- Mylan- Pfizer- Abbott- Sun Pharma- Aspen- Fresenius Kabi- SanofiA company profile gives you the following information where available:- Discussion of a company's activities and outlook- Generic drugs revenue and share of total revenue- Historic revenue (where available), analysis and discussion of company performance- Analysis of major products currently on the market- Acquisitions and strategic partnershipsDiscover capabilities, progress, and commercial prospects, helping you stay ahead.What issues will affect the generic drugs industry?Our new report discusses issues and events affecting the generic drugs market. You will find discussions, including qualitative analyses:- Highly fragmented and competitive market with significant variations in different geographic regions- Changing political and regulatory landscape changing the prospects of future products and reimbursement opportunities- Future generic drug opportunitiesYou will see discussions of technological, commercial, and economic matters, with emphasis on the competitive landscape and business outlooks.How the Generic Drugs Market Forecast 2016-2026: Growth in Leading Regional and National Markets report helps youIn summary, our 306-page report gives you the following knowledge:- Revenue forecasts to 2026 for the Generic Drugs market – discover the industry's prospects, finding promising places for investments and revenues- Revenue forecasts to 2026 for major regional markets – US, EU5, Asia-Pacific, Emerging markets- Revenue forecasts to 2026 for fourteen leading national markets – US, Germany, UK, France, Italy, Spain, China, Japan, India, Brazil, Russia, Mexico, South Korea and Turkey- Assessment of leading companies – analysis of products, revenue (where available), mergers & acquisitions, and pipelines- Discussion of what stimulates and restrains companies and the market- Prospects for established firms and those seeking to enter the marketYou will find quantitative and qualitative analyses with independent predictions. You will receive information that only our report contains, staying informed with this invaluable business intelligence.Information found nowhere elseWith our survey you are less likely to fall behind in knowledge or miss opportunities. See how you could benefit your research, analyses, and decisions. Also see how you can save time and receive recognition for commercial insight.Visiongain's study is for everybody needing commercial analyses for the generic drugs market and leading companies. You will find data, trends and predictions. Please order our report now.Read the full report: Reportlinker ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.http://www.reportlinker.com__________________________Contact Clare: clare@reportlinker.comUS: (339)-368-6001Intl: +1 339-368-6001

To view the original version on PR Newswire, visit:

SOURCE Reportlinker

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z


News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store